✦ LIBER ✦

Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes

✍ Scribed by Deacon, Carolyn F; Holst, Jens J

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dipeptidyl Peptidase-4 Inhibitors for th

✍ Dr. Joshua J. Neumiller; Dr. Lindy Wood; Mr. R. Keith Campbell 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB

Saxagliptin: a new dipeptidyl peptidase-

✍ Carolyn F. Deacon; Jens J. Holst 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 223 KB

Linagliptin , a dipeptidyl peptidase-4 i

✍ Forst, Thomas; Pfützner, Andreas 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 257 KB

Sitagliptin: A Dipeptidyl Peptidase IV I

✍ Miller, S. A 📂 Article 📅 2006 🏛 Harvey Whitney Books Company 🌐 English ⚖ 137 KB

Dipeptidyl Peptidase-4 Inhibitors for th

✍ Herman, G A; Stein, P P; Thornberry, N A; Wagner, J A 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 160 KB

Clinical pharmacology of alogliptin, a d

✍ Christopher, Ronald; Karim, Aziz 📂 Article 📅 2009 🏛 Expert Reviews 🌐 English ⚖ 691 KB